Unknown

Dataset Information

Reporting of late-onset immune-related adverse events with immune checkpoint inhibitors in VigiBase.


ABSTRACT:

Background

To date, evidence on late-onset immune-related adverse events (irAEs) with immune checkpoint inhibitors (ICIs) is limited to a small number of clinical cases. This study aimed to identify drug- and patient-related characteristics potentially associated with the reporting of late-onset irAEs with ICIs in VigiBase, the WHO global database of individual case safety reports (ICSRs).

Methods

Observational study comparing deduplicated ICSRs with ICIs reporting late-onset irAEs (occurred >90 days after ICI discontinuation) versus ICSRs with ICIs not reporting late-onset irAEs, collected in VigiBase from 2011 to December 31, 2022. Logistic regression was used to model the relationship between drug-related and patient-related characteristics of ICSRs and the reporting of l

SUBMITTER: Noseda R 

PROVIDER: S-EPMC11535709 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature